細(xì)胞穿透肽的研究進(jìn)展_第1頁(yè)
細(xì)胞穿透肽的研究進(jìn)展_第2頁(yè)
細(xì)胞穿透肽的研究進(jìn)展_第3頁(yè)
細(xì)胞穿透肽的研究進(jìn)展_第4頁(yè)
細(xì)胞穿透肽的研究進(jìn)展_第5頁(yè)
已閱讀5頁(yè),還剩11頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Recentprogressofcell-penetratingpeptidesasnewcarriersfor

intracellularcargodeliveryPart1BackgroundPart2CPPsclassificationPart3chemicallinkageofCPPsPart4CPPstransmembranemechanismPart5CPPsApplicationsCONTENTSContentsBackgroundCPPscellmembraneselectivelypermeablebarrierCell-penetratingpeptides(CPPs)fewerthan30aminoacids、entercells、endocytosis、conjugatedbioactivecargos[1]AdvantagesofCPPsBiologicalsafety、cellularuptake、bedesigned、LowcytotoxicityCPPsapplicationsiRNA,nucleicacids,proteins、Nanoparticles、Chemotherapydrugs、Liposomes[2-6]CPPsclassificationCPPsequencesareknowntovaryconsiderablyasseenbyTable1.Similarities:positivelychargedaminoacids(R、K)Themembranolyticproperties:positivelycharge,secondarystructure,specificallyhelicityCPPsclassificationEventhoughCPPshaveagreatsequencevariety,itispossibleto

bemainlydividedintothreesubgroupsdefinedbytheirphysical–

chemicalproperties:cationic,amphipathicandhydrophobic。[7]CationicCPPsCationicpeptidesareaclassofpeptideswithahighpositivenetchargeandfewacidicaminoacidresidues.Typical,thecationicCPPsareincludingR9,Tat,hLFand(RXR)4andsoon.AmphipathicCPPsAmphiphiliccell-penetratingpeptidesarecomposedmainlyoflysine。Therearealsodistributedtootherhydrophilicorhydrophobicaminoacidresiduesinthesequence,whichspatialconformationofα-helixstructure。Amphoterichelixhavinghydrophilicandhydrophobicpropertiesisnecessaryforthestructurethroughthemembrane。suchaspVEC、ARFandproline-richpeptides。CPPsclassificationHydrophobicCPPsPeptideswhichcontainonlyapolarresiduesareconsideredashydrophobic

peptides。Sofar,onlyafewhydrophobicCPPsequenceshavebeendiscoveredsuchasthesignalsequencesfrom

integrinβ3(VTVLALGALAGVGVG)andKaposifibroblastgrowthfactor

(AAVALLPAVLLALLAP)chemicallinkageofCPPschemicallinkageofCPPsExamples

ofcovalentconjugationareneutralcargo(phosphorodiamidate

morpholinooligomers(PMO),peptide

nucleicacids(PNA),smalldrugmolecules)complexes

whichcanbecoupledtoCPPsviaadisulfidebond,an

amidebond,orotherspecificlinkers.Noncovalent

complexesareformedviaelectrostaticand/orhydrophobic

interactionsbetweennegativelychargedcargo

molecules,suchasnucleicacids(siRNA,pDNA,etc.),andapositivelychargedCPP.CPP-cargocomplexesneedtoescape

fromtheendosmalvesiclesinordertoinducea

biologicaleffect.Ways:Onelineofthinkingisthathydrophobicandelectrostaticinteractionsoccurbetweentheendosomalmembraneandthenanoparticles,whichleadstodisruptionof

theendosomes.Anothertheprotonspongetheory,proposesthatendosomesburstduetoosmotic

pressureCPPstransmembranemechanismCPPstransmembranemechanismRoleofEndocytosis.Endocytosis,includingphagocytosis

andpinocytosis.Phagocytosisisacomplex

processusedtouptakelargeparticlessuchas

othercells,viruses,orbacteria,whilepinocytosisis

mainlyusedtouptakesmallerparticles.Endocytosis

occursbytheactionofvariouspathwayswhichcanbe

classifiedintocaveolaeand/orlipid-raft-mediated

endocytosis,

macropinocytosis,cholesterol-dependent

clathrin-mediatedendocytosis,orcaveolae-and

clathrin-independentendocytosisDirecttranslocationthroughthemembranebilayerCPPsApplicationsCPPsApplicationsProperlydevelopedCPPsandtheirconjugates

withtherapeuticsofferaverypromisingpathwayto

deliverlowerconcentrationsoftoxicdrugstocritical

tissuessuchastumors,heart,etc.Smallchemotherapeutic

drugshavealsobeendeliveredbyCPPs(doxorubicin,methotrexate,cyclosporineA,paclitaxel).[8]Cducedabiologicallyactive

Bcl-xLfusionproteincontainingan11aminoacidCPP

fromTATproteinandahemagglutinin(HA)tagthat

allowedinvitroandinvivodeliveryintoneurons[9]Otherfuctionsuchaspromotingintestinalabsorptionofinsulin,Newpeptideforoculartissuetransport-PODandsoon.Conclusioncell-penetratingpeptidescanefficientlytraversethe

plasmamembraneofbothcellsandtissuesandare

successfullyusedasdeliveryvectorsfortherapeutic

molecules.Duetotheirpositivecharge,CPPscan

becovalently

conjugatedtoactivebiomolecules(nucleicacids,peptides,proteins,chemotherapeuticdrugs,etc.).After

efficientcellularinternalization,CPPsareabletorelease

theircargointothecytosolinordertopromote

thedesiredbiologicaleffect.Whencoupledtoacargo,

CPPsuseendocytosisasthemaincellulartranslocation

mechanism.Priortouse,CPPsmustundergobothpharmacologicalandtoxicological

studiesinvivo.Consideringevidencefromnumerous

studies,CPPshavethepotentialtobecomeauniversal

tooltocarrytherapeuticmoleculesacrosscellular

membraneswithoutariskoftoxicityorinflammatory

reactionsReference[1]D.M.Copolovici,K.Langel,E.Eriste,U.Langel,Cell-penetratingpeptides:design,synthesis,andapplications.ACSNano8(2014)1972-1994.[2]H.Raagel,P.Saalik,M.Hansen,U.Langel,M.Pooga,CPP-proteinconstructsinduceapopulationofnon-acidicvesiclesduringtraffickingthroughendo-lysosomalpathway.JControlRelease139(2009)108-117.[3]F.SaidHassane,A.F.Saleh,R.Abes,M.J.Gait,B.Lebleu,Cellpenetratingpeptides:overviewandapplicationstothedeliveryofoligonucleotides.CellMolLifeSci67(2010)715-726.[4]M.Lewin,N.Carlesso,C.H.Tung,X.W.Tang,D.Cory,D.T.Scadden,R.Weissleder,Tatpeptide-derivatizedmagneticnanoparticlesallowinvivotrackingandrecoveryofprogenitorcells.NatBiotechnol18(2000)410-414.[5]E.A.Dubikovskaya,S.H.Thorne,T.H.Pillow,C.H.Contag,P.A.Wender,Overcomingmultidrugresistanceofsmall-moleculetherapeuticsthroughconjugationwithreleasableoctaargininetransporters.ProcNatlAcadSciUSA105(2008)12128-12133.[6]V.P.Torchilin,R.Rammohan,V.Weissig,T.S.Levchenko,TATpeptideonthesurfaceofliposomesaffordstheirefficientintracellulardeliveryevenatlowtemperatureandinthepresenceofmetabolicinhibitors.ProcNatlAcadSciUSA98(2001)8786-8791.[7]S.B.Fonseca

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論